170 related articles for article (PubMed ID: 36864361)
1. An exploration of the feasibility and clinical value of half-dose 5-h total-body
Adili D; Cai D; Wu B; Yu H; Gu Y; Zhang Y; Shi H
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2375-2385. PubMed ID: 36864361
[TBL] [Abstract][Full Text] [Related]
2.
Zhang X; Zhou J; Sun Y; Shi H; Ji Z; Jiang L
Clin Rheumatol; 2018 Jul; 37(7):1927-1935. PubMed ID: 29299706
[TBL] [Abstract][Full Text] [Related]
3.
Fan J; Wei D; Zhang H; Sun X; Cai J; Fan L; Yu J; Ma W; Song L; Zhou X
Clin Rheumatol; 2021 Feb; 40(2):625-633. PubMed ID: 32562071
[TBL] [Abstract][Full Text] [Related]
4. (18)F-Fluorodeoxyglucose positron emission tomography and serum cytokines and matrix metalloproteinases in the assessment of disease activity in Takayasu's arteritis.
Arraes AE; de Souza AW; Mariz HA; Silva NP; Torres IC; Pinto PN; Lima EN; Sato EI
Rev Bras Reumatol Engl Ed; 2016; 56(4):299-308. PubMed ID: 27476622
[TBL] [Abstract][Full Text] [Related]
5. The role of (18) F-fluorodeoxyglucose-positron emission tomography in the assessment of disease activity in patients with takayasu arteritis.
Lee KH; Cho A; Choi YJ; Lee SW; Ha YJ; Jung SJ; Park MC; Lee JD; Lee SK; Park YB
Arthritis Rheum; 2012 Mar; 64(3):866-75. PubMed ID: 21989701
[TBL] [Abstract][Full Text] [Related]
6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
7. Comparison of F18-FDG PET/CT findings with current clinical disease status in patients with Takayasu's arteritis.
Karapolat I; Kalfa M; Keser G; Yalçin M; Inal V; Kumanlioğlu K; Pirildar T; Aksu K
Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S15-21. PubMed ID: 23075530
[TBL] [Abstract][Full Text] [Related]
8. A novel model to assess disease activity in Takayasu arteritis based on 18F-FDG-PET/CT: a Chinese cohort study.
Ma LY; Wu B; Jin XJ; Sun Y; Kong XF; Ji ZF; Chen RY; Cui XM; Shi HC; Jiang LD
Rheumatology (Oxford); 2022 Apr; 61(SI):SI14-SI22. PubMed ID: 34156465
[TBL] [Abstract][Full Text] [Related]
9. Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET coregistered with enhanced CT.
Kobayashi Y; Ishii K; Oda K; Nariai T; Tanaka Y; Ishiwata K; Numano F
J Nucl Med; 2005 Jun; 46(6):917-22. PubMed ID: 15937300
[TBL] [Abstract][Full Text] [Related]
10. Metabolic inflammatory volume and total inflammatory glycolysis: novel parameters to evaluate PET-CT disease activity in Takayasu arteritis.
Ora M; Misra DP; Kavadichanda CG; Singh K; Rathore U; Jain N; Agarwal V; Gambhir S
Clin Rheumatol; 2023 Jul; 42(7):1855-1861. PubMed ID: 37055597
[TBL] [Abstract][Full Text] [Related]
11. Value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of pulmonary artery activity in patients with Takayasu's arteritis.
Gao W; Gong JN; Guo XJ; Wu JY; Xi XY; Ma ZH; Yang YH; Yang MF
Eur Heart J Cardiovasc Imaging; 2021 Apr; 22(5):541-550. PubMed ID: 32793972
[TBL] [Abstract][Full Text] [Related]
12. F-18 FDG PET/CT in the evaluation of Takayasu arteritis: an experience from the tropics.
Santhosh S; Mittal BR; Gayana S; Bhattacharya A; Sharma A; Jain S
J Nucl Cardiol; 2014 Oct; 21(5):993-1000. PubMed ID: 24875577
[TBL] [Abstract][Full Text] [Related]
13. Head-to-head intra-individual comparison of total-body 2-[
Chen X; Hu P; Yu H; Tan H; He Y; Cao S; Zhou Y; Shi H
Eur Radiol; 2023 Nov; 33(11):7890-7898. PubMed ID: 37338551
[TBL] [Abstract][Full Text] [Related]
14.
Incerti E; Tombetti E; Fallanca F; Baldissera EM; Alongi P; Tombolini E; Sartorelli S; Sabbadini MG; Papa M; De Cobelli F; Mason JC; Gianolli L; Manfredi AA; Picchio M
Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1109-1118. PubMed ID: 28180963
[TBL] [Abstract][Full Text] [Related]
15. Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences.
Tezuka D; Haraguchi G; Ishihara T; Ohigashi H; Inagaki H; Suzuki J; Hirao K; Isobe M
JACC Cardiovasc Imaging; 2012 Apr; 5(4):422-9. PubMed ID: 22498333
[TBL] [Abstract][Full Text] [Related]
16. Comparing Semiquantitative and Qualitative Methods of Vascular
Dashora HR; Rosenblum JS; Quinn KA; Alessi H; Novakovich E; Saboury B; Ahlman MA; Grayson PC
J Nucl Med; 2022 Feb; 63(2):280-286. PubMed ID: 34088771
[TBL] [Abstract][Full Text] [Related]
17. The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis.
Webb M; Chambers A; AL-Nahhas A; Mason JC; Maudlin L; Rahman L; Frank J
Eur J Nucl Med Mol Imaging; 2004 May; 31(5):627-34. PubMed ID: 14730404
[TBL] [Abstract][Full Text] [Related]
18. Is (18)F-fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in Takayasu arteritis?
Arnaud L; Haroche J; Malek Z; Archambaud F; Gambotti L; Grimon G; Kas A; Costedoat-Chalumeau N; Cacoub P; Toledano D; Cluzel P; Piette JC; Amoura Z
Arthritis Rheum; 2009 Apr; 60(4):1193-200. PubMed ID: 19333926
[TBL] [Abstract][Full Text] [Related]
19. A retrospective cohort study to assess PET-CT findings and clinical outcomes in Takayasu arteritis: does 18F-fluorodeoxyglucose uptake in arteries predict relapses?
Janes ALF; Castro MF; Arraes AED; Savioli B; Sato EI; de Souza AWS
Rheumatol Int; 2020 Jul; 40(7):1123-1131. PubMed ID: 32200427
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET/CT in Late Acquisition Identifies Sites of Active Disease in Treated Takayasu Arteritis.
de Souza Santos MP; Ramos CD; Paixão M; Pignaton Naseri E; Barros Bertolo M; Sachetto Z
J Clin Rheumatol; 2022 Jan; 28(1):14-20. PubMed ID: 34941616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
